Evaxion Biotech AS (EVAX)
4.05
-0.12
(-2.88%)
USD |
NASDAQ |
May 01, 15:55
Evaxion Biotech Profit Margin (Quarterly): -6.20K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -6.20K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.20K%
Minimum
Dec 2023
-6.20K%
Maximum
Dec 2023
-6.20K%
Average
-6.20K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
Ascendis Pharma A/S | -63.09% |
DBV Technologies SA | -- |
Cellectis SA | -11.28K% |
Adaptimmune Therapeutics PLC | -20.74K% |
Akari Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
Operating Margin (Quarterly) | -5.98K% |